Savara (SVRA) Share-based Compensation (2010 - 2026)

Savara's (SVRA) quarterly Share-based Compensation came in at $22.5 million in Q1 2026, up 657.07% year-on-year from $3.0 million in Q1 2025, and up 320.17% on a QoQ basis from $5.4 million in Q4 2025.

Savara (SVRA) Share-based Compensation (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Share-based Compensation data on file, last reported at $22.5 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 657.07% year-over-year to $22.5 million in Q1 2026; TTM through Mar 2026 was $22.5 million, a 112.77% increase from a year earlier, with the FY2025 full-year figure at $14.4 million, up 23.26% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $22.5 million, up from $5.4 million in the prior quarter.
  • Over the last five years, Share-based Compensation for SVRA reached as high as $22.5 million in Q1 2026 and fell as low as $450000.0 in Q3 2022.
  • Historically, Share-based Compensation has averaged $3.7 million across 5 years, with a median of $2.2 million in 2024.
  • Across the five-year window, Share-based Compensation sank 40.86% in 2022 and surged 657.07% in 2026, its largest moves.
  • Year by year, Share-based Compensation stood at $561000.0 in 2022, then jumped by 142.6% to $1.4 million in 2023, then surged by 123.07% to $3.0 million in 2024, then jumped by 76.38% to $5.4 million in 2025, then surged by 320.17% to $22.5 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $22.5 million in Q1 2026, $5.4 million in Q4 2025, and $14.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Savara 1.24 Bn 1.24 Bn - 22.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.50 Mn
Mar 31, 2026 22.50 Mn
Dec 31, 2025 5.36 Mn
Dec 31, 2025 5.36 Mn
Sep 30, 2025 14.10 Mn
Sep 30, 2025 14.10 Mn
Jun 30, 2025 2.67 Mn
Jun 30, 2025 2.67 Mn
Mar 31, 2025 2.97 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 3.04 Mn
Dec 31, 2024 3.04 Mn
Sep 30, 2024 2.37 Mn
Sep 30, 2024 2.37 Mn
Jun 30, 2024 2.20 Mn
Jun 30, 2024 2.20 Mn
Mar 31, 2024 2.26 Mn
Mar 31, 2024 2.26 Mn
Dec 31, 2023 1.36 Mn
Dec 31, 2023 1.36 Mn